Platform Analysis Compares Compounded Prescription Tablets vs. Injectable Format as Consumer Search Volume for "Sermorelin ...

This review highlights relevant physicochemical drug properties and formulation design considerations critical to quality and performance of the sublingual tablets. The oral mucosal lining offers a ...

Lannett announced that the Food and Drug Administration (FDA) has approved Buprenorphine and Naloxone Sublingual Tablets, the generic version of Reckitt Benckiser's Suboxone Sublingual Tablets.

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study Patients receiving stable opioid therapy ...

First sublingual tablet for grass allergies approved The FDA has cleared the once-daily tablet Oralair to treat grass-pollen induced allergic rhinitis with or without conjunctivitis. HealthDay News — ...

The pooled analysis (N=804) evaluated clinical studies of sufentanil sublingual tablet (SST) at 30mcg dose equivalents over ≤72 hours for moderate-to-severe acute pain management in both postoperative ...

REDWOOD CITY, Calif., April 11, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative ...

Passing a rolled joint of marijuana flower may soon be replaced with passing an eye-dropper full of THC liquid. Cannabis-infused sublingual and tincture products, drops, tablets and strips placed ...

Buprenorphine sublingual tablet is prescribed to treat opioid use disorder in two phases: an induction phase to manage initial withdrawal symptoms and a maintenance phase for long-term treatment. You ...

Lundbeck and Merck sign exclusive commercialisation agreement for SYCREST® (asenapine) sublingual tablets in all markets outside of the United States, China and Japan Release date: 12-10-2010 SYCREST® ...

Allergens modified by carbamylation so that they can be absorbed by the oral mucosa and given as sublingual immunotherapy have once again been found to be effective in patients with ...